| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 7e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |